Latest Breaking News On - Hesaam esfandyarpour - Page 1 : vimarsana.com
GenapSys, a Redwood City, CA-based company developing a scalable electronic sequencing platform, raised $70m in Series D equity financing.
Backers included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM Capital, and additional new investors. In conjunction with the funding, Bob Zollars and a representative of Farallon Capital have been appointed to GenapSys’ Board of Directors.
The company intends to use the funds to continue advancing its semiconductor based next-generation sequencing (NGS) platform.
Led by Jason Myers, Ph.D., Chief Executive Officer, and Founder and Chairman Dr. Hesaam Esfandyarpour, GenapSys is a company focused on the advancement of universal access to genomic information by delivering a genomic sequencing ecosystem that empowers both academic and clinical research applications. Its system leverages a proprietary electrical microfluidic sequencing chip with a scalable number of detectors, allowing for a wide range of application
Arizona
United-states
Bob-zollars
Jason-myers
Hesaam-esfandyarpour
Research-use
Johnf-kennedy-university
Arizona-state-university
Cardinal-health
Vocera-communications-inc
Redwood-city
Farallon-capital-management
(0)
Capital will enable continued advancement of GenapSys electronic-based, next-generation sequencing platform
REDWOOD CITY, Calif., May 27, 2021 /PRNewswire/ GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM Capital, and additional new investors. Proceeds from this financing will be used to continue advancing GenapSys semiconductor based next-generation sequencing (NGS) platform. We are delighted to partner with this world-class group of investors who together share our broad strategic vision of delivering an affordable, scalable genomic sequencing ecosystem that empowers both academic and clinical research, said Jason Myers, Ph.D., Chief Executive Officer of GenapSys. We look forward to leveraging our Board s strategic insight to acce
Arizona
United-states
David-deuchler
Bob-zollars
Kostenloser-wertpapierhandel
Jason-myers
Surekha-karudapuram
Hesaam-esfandyarpour
Arizona-state-university
Prnewswire-genapsys-inc
Research-use
Johnf-kennedy-university